GlassScriptPhysician profile
Edwin Charles Weiss
NPI 1528035458
$1,367.27
in general payments reported to CMS, 2019-2025
10 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2022: $11.71 · 2023: $13.12 · 2024: $43.39 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $408.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $400.00 | 2019 | |
| Pfizer INC. | $247.29 | 2019 | |
| Exact Sciences Corporation | $122.43 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $52.35 | 2025 | Verquvo |
| Biobeat USA INC. | $43.39 | 2024 | Bb-613 Bpm Kit |
| Lilly USA, LLC | $29.03 | 2022-2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $27.02 | 2019 | |
| Amarin Pharma, INC. | $24.62 | 2019 | |
| Novo Nordisk INC | $13.12 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.